AbbVie (NYSE:ABBV) Lifted to “Buy” at The Goldman Sachs Group
The Goldman Sachs Group upgraded shares of AbbVie (NYSE:ABBV – Free Report) from a neutral rating to a buy rating in a report published on Monday, Marketbeat reports. The firm currently has $173.00 price target on the stock. Other analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft began coverage on […]
More Stories
Request Price Hits $0.11 (REQ)
Request (REQ) traded up 5.3% against the US dollar during the 24 hour period ending at 11:00 AM Eastern on...
Wharton Business Group LLC Has $367,000 Stock Holdings in United Parcel Service, Inc. (NYSE:UPS)
Wharton Business Group LLC decreased its position in shares of United Parcel Service, Inc. (NYSE:UPS – Free Report) by 5.3%...
Unum Group (NYSE:UNM) Hits New 12-Month High – Time to Buy?
Unum Group (NYSE:UNM – Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The...
Walgreens Boots Alliance (NASDAQ:WBA) Sets New 12-Month Low – Time to Sell?
Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Free Report)’s share price reached a new 52-week low during mid-day trading on...
Old Republic International (NYSE:ORI) Sets New 52-Week High – What’s Next?
Old Republic International Co. (NYSE:ORI – Get Free Report)’s share price hit a new 52-week high during mid-day trading on...
ATI Physical Therapy, Inc. (NYSE:ATIP) Short Interest Update
ATI Physical Therapy, Inc. (NYSE:ATIP – Get Free Report) was the target of a significant increase in short interest during...